Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Optimal perioperative analgesia in hand surgery
ISRCTN ISRCTN97731480
ClinicalTrials.gov identifier
Public title Optimal perioperative analgesia in hand surgery
Scientific title
Acronym N/A
Serial number at source MCT-65009
Study hypothesis To compare two methods of analgesia, optimal perioperative analgesia OPA versus the usual analgesic treatment (UAT), in patients undergoing hand surgery, in terms of postoperative pain control, intensity and duration of the local inflammatory response, impact of pain on function and quality of life.

Trapeziectomy and carpal surgery, bone graph, wrist arthrodesis, distal radial arthrotomy, hand surgery/trauma of hand.
Lay summary
Ethics approval Ethics approval received from the Comité d'éthique de la recherche, CHUM (Centre Hospitalier de l'Université de Montréal) on the 24th March 2003.
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Hand surgery
Participants - inclusion criteria Patients, either sex, scheduled for trapeziectomy and carpal surgery:
1. Total and partial carpectomy
2. Bone graph
3. Wrist arthrodesis
4. Distal radial arthrotomy
Participants - exclusion criteria 1. Age under 18 years or older than 75 years
2. Pregnant
3. Allergic to morphine, local anesthetics
4. Suffering from other forms of chronic arthritis or other painful conditions treated chronically (every day) with analgesics (i.e. fibromyalagia)
5. Allergic or intolerant to NSAID (COX2 inhibitors)
6. Consuming anticoagulants which cannot be interrupted
7. Suffering from major cardiovascular problems
8. Suffering from cognitive or psychiatric problems, or drug abuse
9. Other recent hand surgery or axillary surgery with sequels
10. Living alone (no help at home)
11. Unable to understand French or English
12. Without phone access or likely to change address during follow-up
Anticipated start date 01/10/2003
Anticipated end date 30/09/2006
Status of trial Completed
Patient information material
Target number of participants 220
Interventions Experimental group: non-steroidal anti-inflammatory drug (NSAID) 1 hour before surgery, 1 daily after surgery.
Both groups (OPA and UAT) will receive the same treatment until their admission in the recovery room.

Trial details received: 12 September 2005
Primary outcome measure(s) Reducing pain intensity at rest and during active movements measured at 8 months.
Secondary outcome measure(s) 1. The impact of pain on Quality of Life (QOL)
2. The impact of pain on activities
3. Inflammation
4. Function
Sources of funding Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-65009)
Trial website
Publications
Contact name Dr  Gilbert Alfred  Blaise
  Address Hôpital Notre-Dame du CHUM
Laboratoire d'Anesthésie
Porte FS-1136
1560 rue Sherbrooke Est
  City/town Montréal
  Zip/Postcode H2L 4M1
  Country Canada
  Tel +1 514-890-8202
  Fax +1 514-412-7520
  Email blaisegil@sympatico.ca
Sponsor University Hospital of Montreal (CHUM) (Canada)
  Address Campus Hôtel-Dieu
3840 rue Saint-Urbain
  City/town Montréal
  Zip/Postcode H2W 4M1
  Country Canada
Date applied 26/09/2005
Last edited 10/12/2007
Date ISRCTN assigned 26/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central